Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Dividends Paid - Common (2020 - 2025)

Definitive Healthcare's Dividends Paid - Common history spans 6 years, with the latest figure at $321000.0 for Q4 2025.

  • For Q4 2025, Dividends Paid - Common fell 86.19% year-over-year to $321000.0; the TTM value through Dec 2025 reached $2.7 million, down 76.9%, while the annual FY2025 figure was $3.1 million, 38.7% down from the prior year.
  • Dividends Paid - Common reached $321000.0 in Q4 2025 per DH's latest filing, down from $2.3 million in the prior quarter.
  • In the past five years, Dividends Paid - Common ranged from a high of $7.9 million in Q3 2023 to a low of $98000.0 in Q3 2024.
  • Average Dividends Paid - Common over 5 years is $2.8 million, with a median of $2.3 million recorded in 2024.
  • Peak YoY movement for Dividends Paid - Common: soared 499.8% in 2022, then crashed 98.75% in 2024.
  • A 5-year view of Dividends Paid - Common shows it stood at $989000.0 in 2021, then skyrocketed by 499.8% to $5.9 million in 2022, then crashed by 73.21% to $1.6 million in 2023, then skyrocketed by 46.26% to $2.3 million in 2024, then plummeted by 86.19% to $321000.0 in 2025.
  • Per Business Quant, the three most recent readings for DH's Dividends Paid - Common are $321000.0 (Q4 2025), $2.3 million (Q4 2024), and $98000.0 (Q3 2024).